Disminished zinc plasma concentrations and alterations in the number of lymphocyte subpopulations in Down's syndrome patients;Disminución de las concentraciones plasmáticas de cinc y alteraciones numéricas de subpoblaciones de linfocitos en pacientes con síndrome de down

Investigacion Clinica

Volumn 44, Issue 1, 2003, Pages 51-60

  Soto Quintana, Marisol ^a,d   Álvarez Nava, Francisco ^a   Rojas Atencio, Alicia ^a   Granadillo, Victor ^b   Fernández, Denny ^b   Ocando, Ana ^b   López, Ealys ^a   Fulcado, Waleska ^c  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

^b FACULTAD DE CIENCIAS VETERINARIAS   (Venezuela)

^c Hospital General del Sur   (Venezuela)

^d UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

Down syndrome; Lymphocyte subpopulations; Zinc

Indexed keywords

CD16 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; ZINC;

ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE SYSTEM; INFANT; MALE; MENTAL DEFICIENCY; NUTRITIONAL DEFICIENCY; PRESCHOOL CHILD; T LYMPHOCYTE SUBPOPULATION; ZINC BLOOD LEVEL; ZINC DEFICIENCY;

CHILD; CHILD, PRESCHOOL; DOWN SYNDROME; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNE SYSTEM; INFANT; INFANT, NEWBORN; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; SPECTROPHOTOMETRY, ATOMIC; ZINC;

EID: 0344406217     PISSN: 05355133     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Estevez J, Chacin I, Bonilla E, Villalobos R. Concentraciones de cobre y cinc en una población suburbana del estado Zulia (Venezuela). Invest Clin 1988; 29: 97-109.
2. Reinhold J. Trace Elements- A selective survey. Clin Chem 1975; 21: 476-500.
3. Meyer H, Rune E, Riise T, Fosse G, Ramsten G. Zinc in primary teeth from children in Norway. The Science of the Total Environment 1999; 226: 201-212.
4. Vallee B. Zinc: biochemistry, physiology, toxicology and clinical pathology. Biofactors 1988; 1: 31-36.
5. Zanzonico P, Fernandes G, Good R. The differential sensitivity of T-cell and B-cell mitogenesis to in vitro zinc deficiency. Immunol 1981; 60: 203-211.
6. Lockitch G, Puterman M, Godolphin W, Sheps S, Tingle A, Quigley G. Infection and immunity in Down syndrome: a trial of long-term low oral doses of zinc. J Pediatr 1989; 114: 781-787.
7. Arcasoy A, Yildirmak T, Yildirmak Y, Tune S, Sinav B, Kutluay I. A test in the diagnosis of marginal zinc deficiency in the geriatric people: serum zinc binding capacity. Trace Elem Electrolytes 2001; 18 (3): 139-141.
8. Licastro F, Mocchegiani E, Masi M, Fabris N. Modulation of the neuroendocrine system and immune functions by zinc supplementation in children with Down's syndrome. J Trace Elem Electrolytes Health Dis 1993; 7: 237-239.
9. Bach J, Dardenne M. Clinical aspects of thymulin (FTS) In: Goldstein AL, Ed, Thymic hormones and lymphokines. New York: Plenum Press; 1984. p 593-600.
10. Dardenne M, Pleauj, Nabarra B. Contribution of zinc and other metals to the biological activity of the serum thymic factor. Proc Natl Acad Sci USA 1982; 79: 5370-5373.
11. Cengiz M, Seven M, Cengiz S, Yuskel A, Iscan M. Vitamin and mineral status in Down syndrome. Trace Elem Electrolytes 2000; 17(3): 156-160.
12. Soto M, Pineda L, Rojas A, Álvarez F, Cañizales J, Prieto M. Síndrome de Down: origen parental, asociaciones de satélites y regiones organizadoras nucleolares. Ciencia 1997; 5(2): 121-129.
13. Taylor G, Williams A, D'souza S, Fergusson W, Donnai D, Fennell J., Harris R. The expression of CD18 is increased on trisomy 21 (Down syndrome) lymphoid cell. Clin Exp Immunol 1988; 71: 324-328.
14. st Ed. New York: Marcel Dekker, Inc; 1994. p 253-264.
15. Oster J, Mikkelsen M, Nielsen A. Mortality and lifetable in Down's syndrome. Acta Paediatr Scand 1975; 64: 322-326.
16. Milunsky A, Hackley B, Halsted J. Plasma, erythrocyte and leucocyte zinc levels in Down's syndrome. J Ment Defic Res 1970; 14: 99-105.
17. Rascon M, Lorente F, Salazar A, Villalobos V. Evaluation of plasma zinc levels in patients with Down syndrome. Ann Esp Pediatr 1992; 37 (5): 391-393.
18. Bjorksten B, Back O, Gustavson K, Hallmans G, Hagglof B, Tarnvick A. Zinc and immune function in Down's syndrome. Acta Paediatr Scand 1980; 69: 183-187.
19. Kanavin O, Scott H, Fausa O, Johan E, Gaarder P, Brandtzaeg P. Immunological studies of patients with Down's syndrome. Acta Med Scand 1988; 224: 473-477.
20. Ugazio A, Maccario R, Notarangelo I, Burgio R. Immunology of Down syndrome: a review. Am J Med Genet 1990; 7: 204-212.
21. Stabile A, Pesaresi M, Stabile M, Pastore M, Sopo M, Ricci R, Celestini E, Segni G. Immunodeficiency and plasma zinc levels in children with Down's syndrome: a long-term follow-up of oral zinc suplementation. Clin Immunol Immunopathol 1991; 58: 207-216.
22. Noble R, Warren P. Analysis of blood cell populations, plasma zinc and natural killer cell activity in young children with Down's syndrome. J Ment Defic Res 1988; 32: 193-201.
23. va Ed. México, D.F.: McGraw-Hill Interamericana; 1996. p 371-395.
24. Moorhead P, Nowell P, Mellman W, Battips D, Hungerford D. Chromosome preparations of leucocytes cultured from human peripheral blood. Exp Cell Res 1960; 20: 613-616.
25. Tahán J, Granadillo V, Romero R. Electrothermal atomic absorption spectrometric determination of AL, Cu, Fe, V, and Zn in clinical samples and in certified environmental reference materials. Anal Chim Acta 1994; 295: 187-197.
26. Hetland O, Brubakk E. Diurnal variation in serum zinc concentration. Scand J Clin Lab Invest 1973; 32:225-226.
27. Lifschitz MD, Henkin RI. Circadian variation in copper and zinc in man. J Appl Physiol 1971;31: 88-92.
28. Cossarizza A, Monti D, Montagnani G, Ortolani C, Masi M, Zannotti M, Franceschi C. Precocious aging of the immune system in Down's síndrome: alteration of B lymphocytes, T-lymphocyte subsets, and cells with natural killer markers. Am J Med Genet 1990; 7:213-218.
29. Soylak M, Saracoglu S, Divrikli U, Elei I. Copper and zinc concentrations of serum samples of healthy people living in Tokat, Turkey. Trace Elem Electrolytes 2001; 18: 47-50.
30. Ohtake M., Tamura T. Serum zinc and copper levels in healthy Japanese children. Tohoku J Exp Med 1976; 120: 99-103.
31. Tietz N. Fundamentals of Chemistry Saunders, Philadelphia; 1987.
32. Burguera J, Burguera M, Alarcon O. Blood levels of zinc, cobalt, copper, iron, and manganese in children from Merida, Venezuela. Trace Elem Med 1992; 9: 194-197.
33. Henking R, Schulman J, Schulman C, Bronzert D. Changes in total, nondiffusible, and diffusible plasma zinc and copper during infancy. J Pediatrics 1973; 82: 831-837.
34. Butrimovitz G, Purdy W. Resolution of age-dependent reference intervals: polynomial regression methodology with applicability to plasma zinc levels in a chilhood population. Clin Biochem 1979; 12: 33-36.
35. Halsted J, Smith J. Plasma-zinc in health and disease. Lancet 1970; 14: 322-324.
36. Franceschi C, Chiricolo M, Licastro F, Zannotti M, Mocchegiani E, Fabris N. Oral zinc supplementation in Down's syndrome: restoration of thymic endocrine activity and of some immune defects. J Ment Defic Res 1988; 32: 169-181.
37. Walravens P. Nutritional importance of copper and zinc in neonates and infants. Clin Chem 1980; 26 (2): 185-189.
38. Parisi A, Vallee B. Zinc metalloenzymes: characteristics and significance in biology and medine. Am J Clin Nutr 1969; 22: 1222-1239.
39. Burgio G, Ugazio A, Nespoli I, Macario R. Down syndrome: a model of immunodeficiency. Birth Defects 1983; 19: 325-327.
40. Philip R, Berger A, Memanus N, Warner N, Peacock M, Epstein I. Abnormalities of the in vitro cellular and humoral responses to tetanus and influenza antigens with concomitant numerical alterations in lymphocytes subsets in Down syndrome (trisomy 21) J Immunol 1986; 136: 1661-1667.
41. Gupta S, Fikring S, Mariano E, Quazi G. Monoclonal antibody defined T cell subsets and autologous mixed lymphocyte reaction in Down's syndrome. Clin Exp Immunol 1983; 53: 25-30.
42. Levin S, Nir E, Mogilner B. T-system immune deficiency in Down's syndrome. Pediatrics 1975; 56:123.
43. Murphy M, Insoft R, Pike-Nobile L, Epstein L. A hypothesis to explain the immune defects in Down syndrome. Etiology and Pathogenesis of Down Syndrome. Wiley-Liss, Inc; 1995, p 147-167.
44. Beisel W. Single nutrients and immunity. Am J Clin Nutr 1982; 35: 417-468.